Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Altria Group
MO
|
+$428M |
| 2 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$232M |
| 3 |
Grayscale Bitcoin Trust
GBTC
|
+$208M |
| 4 |
Morgan Stanley Direct Lending Fund
MSDL
|
+$201M |
| 5 |
Infosys
INFY
|
+$134M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$50.9B |
| 2 |
Apple
AAPL
|
+$38.9B |
| 3 |
Amazon
AMZN
|
+$26B |
| 4 |
NVIDIA
NVDA
|
+$23.3B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.37% |
| 2 | Financials | 10.81% |
| 3 | Healthcare | 9.76% |
| 4 | Consumer Discretionary | 9.08% |
| 5 | Industrials | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5326
Red River Bancshares
RRBI
$669M
| $347K | ﹤0.01% |
6,971
-12,657
| -64% | -$645K |
|
5327
Biote Corp
BTMD
$65.8M
| $347K | ﹤0.01% |
59,770
-66,204
| -53% | -$332K |
|
5328
Dave Inc
DAVE
$5.37B
| $346K | ﹤0.01% |
9,311
+8,207
| +743% | +$189K |
|
5329
BondBloxx USD High Yield Bond Sector Rotation ETF
HYSA
$65.4M
| $346K | ﹤0.01% |
23,023
-56,063
| -71% | -$841K |
|
5330
KORU Medical Systems
KRMD
$189M
| $345K | ﹤0.01% |
146,348
-4,836
| -3% | -$10.4K |
|
|
ACVU
5331
Hartford Alpha Capture Value ETF
ACVU
$183M
| $345K | ﹤0.01% |
14,064
-11,174
| -44% | -$261K |
|
|
MESO
5332
Mesoblast
MESO
$1.94B
| $345K | ﹤0.01% |
68,902
-241,542
| -78% | -$514K |
|
5333
VanEck Africa Index ETF
AFK
$101M
| $345K | ﹤0.01% |
23,661
-24,873
| -51% | -$338K |
|
|
PAI
5334
Western Asset Investment Grade Income Fund
PAI
$114M
| $343K | ﹤0.01% |
28,142
-28,522
| -50% | -$342K |
|
5335
ImmuCell
ICCC
$97.7M
| $343K | ﹤0.01% |
64,716
-104,432
| -62% | -$538K |
|
5336
Butterfly Network
BFLY
$2.3B
| $343K | ﹤0.01% |
317,247
-654,677
| -67% | -$702K |
|
|
GOEV
5337
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $341K | ﹤0.01% |
4,780
-1,960
| -29% | -$136K |
|
|
ROOF
5338
DELISTED
NYLI CBRE NextGen Real Estate ETF
ROOF
| $341K | ﹤0.01% |
17,296
-55,010
| -76% | -$1.07M |
|
5339
Entravision Communication
EVC
$1.06B
| $341K | ﹤0.01% |
208,058
-210,984
| -50% | -$696K |
|
5340
NACCO Industries
NC
$358M
| $341K | ﹤0.01% |
11,288
-16,380
| -59% | -$555K |
|
5341
EA Bridgeway Blue Chip ETF
BBLU
$458M
| $341K | ﹤0.01% |
29,186
-34,214
| -54% | -$377K |
|
5342
Core Scientific
CORZ
$7.12B
| $341K | ﹤0.01% |
+96,187
| New | +$334K |
|
5343
JPMorgan International Growth ETF
JIG
$497M
| $340K | ﹤0.01% |
5,402
-9,834
| -65% | -$593K |
|
5344
First Trust Exchange-Traded Fund VI First Trust BuyWrite Income ETF
FTHI
$2.44B
| $339K | ﹤0.01% |
15,100
+12,898
| +586% | +$283K |
|
5345
Harvard Bioscience
HBIO
$28.9M
| $339K | ﹤0.01% |
8,002
-13,914
| -63% | -$626K |
|
5346
Noodles & Co
NDLS
$107M
| $338K | ﹤0.01% |
22,150
-35,386
| -62% | -$691K |
|
5347
Dakota Gold
DC
$712M
| $338K | ﹤0.01% |
142,800
-157,166
| -52% | -$340K |
|
5348
Nuvectis Pharma
NVCT
$617M
| $338K | ﹤0.01% |
41,191
-4,639
| -10% | -$39.4K |
|
5349
Arteris
AIP
$1.45B
| $336K | ﹤0.01% |
45,939
-67,211
| -59% | -$433K |
|
5350
Innovator US Equity Ultra Buffer ETF October
UOCT
$181M
| $336K | ﹤0.01% |
10,000
-10,000
| -50% | -$330K |
|
Similar funds
Morgan Stanley's Q1 2024 Portfolio in Review
As of Q1 2024, Morgan Stanley held 8,154 positions worth $1.25T, down 45% from $2.27T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Morgan Stanley withdrew a net $1.16T in Q1 2024, closing 331 positions and reducing 6,748 holdings. Its most notable exit was Mirati Therapeutics, Inc. Common Stock, an estimated $725M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Morgan Stanley opened a new position in Grayscale Bitcoin Trust worth $270M.
- Morgan Stanley's largest Q1 2024 buy was Grayscale Bitcoin Trust: 4,729,259 shares worth $270M.
- Morgan Stanley added most to Altria Group in Q1 2024, an estimated $428M increase.
- Morgan Stanley's biggest Q1 2024 reduction was Microsoft, cutting an estimated $50.9B.
- Morgan Stanley fully exited Mirati Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $725M.
- Morgan Stanley's ten largest holdings make up 19% of its $1.25T portfolio in Q1 2024.
- Morgan Stanley opened 333 new positions and closed 331 in Q1 2024.
- Morgan Stanley's portfolio value fell 45% quarter-over-quarter to $1.25T.
Based on Morgan Stanley's 13F filing for Q1 2024, filed 15 May 2024.